Reply to Stricker et al.

Clinical Infectious Diseases

Volumn 46, Issue 6, 2008, Pages 950-951

  Nadelman, Robert B ^a   Wormser, Gary P ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL STRAIN; BORRELIA BURGDORFERI; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LETTER; LYME DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REINFECTION; RELAPSE;

EID: 40949089310     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/528872     Document Type: Letter

References (16)

1. Stricker RB, Corson AF, Johnson L. Reinfection versus relapse in patients with Lyme disease: not enough evidence. Clin Infect Dis 2008; 46:950.
2. Krause PJ, Foley DT, Burke GS, Christianson D, Closter L, Spielman A. Tick-Borne Disease Study Group. Reinfection and relapse in early Lyme disease. Am J Trop Med Hyg 2006; 75:1090-4.
3. Nowakowski J, McKenna D, Nadelman RB, et al. Failure of treatment with cephalexin for Lyme disease. Arch Fam Med 2000; 9:563-7.
4. Falco RC, McKenna DF, Daniels TJ, et al. Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans. Am J Epidemiol 1999; 149:771-6.
5. Melski JW, Reed KD, Mitchell PD, Barth GD. Primary and secondary erythema migrans in central Wisconsin. Arch Dermatol 1993; 129:709-16.
6. Weber K, Neubert U, Büchner SA. Erythema migrans and early signs and symptoms. In: Aspects of Lyme borreliosis. Berlin, Heidelberg, New York: Springer-Verlag, 1993: 105-21.
7. Berger BW. Dermatologic manifestations of Lyme disease. Rev Infect Dis 1989; 11(Suppl 6):1475-81.
8. Malane MS, Grant-Kels JM, Feder HM Jr, Luger SW. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med 1991; 114:490-8.
9. Stibich AS, Schwartz RA. Papular urticaria. Cutis 2001; 68:89-91.
10. Resneck JS Jr, Van Beek M, Furmanski L, et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA 2004; 292:2614-21.
11. Farrell LD, Wong RK, Manders EK, Olmstead PM. Cutaneous myiasis. Am Fam Physician 1987; 35:127-33.
12. Mumcuoglu Y, Rufli T. Siphonaptera/fleas. Schweiz Rundsch Med Prax 1979; 68:1172-82.
13. Nadelman RB, Hanincova K, Madison G, et al. Outer surface protein C (ospC) genotypes in patients with infection and reinfection with Borrelia burgdorferi [abstract 667]. In: Program and abstracts of the 45th Annual Meeting of the Infectious Diseases Society of America (San Diego). Alexandria, VA: Infectious Diseases Society of America, 2007:67.
14. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-134 (erratum: Clin Infect Dis 2007; 45:941).
15. Seinost G, Golde WT, Berger BW, et al. Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease. Arch Dermatol 1999; 135:1329-33.
16. Liveris D, Varde S, Iyer R, et al. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol 1999; 37:565-9.